dopamine
Non-dopaminergic drug preladenant reduces motor fluctuations in patients with Parkinson’s disease
Tampa, FL (Feb. 10, 2011) — Preladenant, a non-dopaminergic medication, reduces off time in patients with Parkinson’s disease receiving standard dopamine therapy, an international study led by the University of South Florida found.
Results of th…
SLU research implicates natural toxin as triggering Parkinson’s disease
ST. LOUIS — In new research from Saint Louis University, investigators have found evidence that a toxin produced by the brain is responsible for the series of cellular events that lead to Parkinson’s disease. The study, published in PLoS One, foun…
Ritalin may ease early iron deficiency damage
Ritalin may help improve brain function in adolescent rats that were iron deficient during infancy, according to a team of Penn State neuroscientists. This may have implications for iron-deficient human infants as well.
The researchers found that …
Genetic trait could triple odds of whites’ susceptibility to heavy cocaine abuse
COLUMBUS, Ohio — Nearly one in five whites could carry a genetic variant that substantially increases their odds of being susceptible to severe cocaine abuse, according to new research.
This genetic variant, characterized by one or both of two…
Euthymics presents phase II data for EB-1010 in major depression at ACNP annual meeting
Euthymics Bioscience, Inc. today will present Phase II clinical data demonstrating that its lead product candidate EB-1010, a next-generation antidepressant, is effective for treating major depressive disorder (MDD) based on multiple standard measur…
Researchers find a ‘liberal gene’
Liberals may owe their political outlook partly to their genetic make-up, according to new research from the University of California, San Diego, and Harvard University. Ideology is affected not just by social factors, but also by a dopamine recept…